Clinical Trial Update: Blood Biomarkers Based Screening for HPV-driven OPC [NA]

View source ↗

Summary

UNICANCER-sponsored trial is evaluating blood biomarker-based screening for HPV-driven cancers, including oropharyngeal cancer, with status NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer
• Head and Neck Squamous Cell Carcinoma
• Human Papillomavirus Infection
• Oropharyngeal Cancer

Snippet

Sponsor: UNICANCER | Conditions: Head and Neck Squamous Cell Carcinoma, Anal Cancer | NA | Status: NOT_YET_RECRUITING